FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Profound Medical Corp. Stock AnalysisComprehensive stock analysis for Profound Medical Corp. (PROF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPROF
PROF
Profound Medical Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PROF
Home🔹Stocks🔹Profound Medical Corp.

Profound Medical Corp.

PROF•NASDAQ

Profound Medical Corp.

PROF•NASDAQ
Market cap
$263.45M
Sentiment

Your view on PROF

Mkt Cap
$263.45M
Sentiment
Your view
PROF
Profound Medical Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PROF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Profound Medical Corp.

Industry
Medical - Devices
Sector
Healthcare
CEO
Arun Swarup Menawat MBA,
Headquarters
2400 Skymark Avenue, Mississauga, ON, CA
Industry
Medical - Devices
Sector
Healthcare
CEO
Arun Swarup Menawat MBA,
Headquarters
2400 Skymark Avenue, Mississauga, ON, CA
Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News